# Influence of Pharmacological Agents on Orthodontic Tooth Movement: A Systematic Review

**Authors:** Lucia Giannini, Federica Macrì, Angelo Michele Inchingolo, Francesco Inchingolo, Gianna Dipalma, Cinzia Maspero

PMC · DOI: 10.3390/bioengineering13020224 · Bioengineering · 2026-02-14

## TL;DR

This systematic review explores how medications affect orthodontic tooth movement, pain, and periodontal outcomes, emphasizing the need for clinical trials.

## Contribution

The study systematically reviews the clinical and biological effects of pharmacological agents on orthodontic outcomes.

## Key findings

- NSAIDs reduce orthodontic pain but may slow tooth movement in a dose-dependent manner.
- Antiresorptive drugs like bisphosphonates are linked to reduced tooth movement.
- Topical antimicrobials and probiotics improve periodontal outcomes without affecting tooth movement.

## Abstract

Background: Pharmacological agents may interfere with the biological processes underlying orthodontic tooth movement (OTM), potentially affecting treatment duration, pain control, and periodontal outcomes. Methods: A systematic review was conducted according to PRISMA 2020 guidelines and registered in PROSPERO. Human studies were prioritized to assess clinically relevant effects on OTM and pain, while animal and in vitro studies were included to support biological interpretation. Results: Sixty-four studies were included. Human evidence indicates that NSAIDs effectively reduce orthodontic pain but may decrease the rate of tooth movement in a dose-dependent manner. Antiresorptive drugs, particularly bisphosphonates, were consistently associated with reduced OTM. Topical antimicrobials, fluoride agents, and probiotics improved periodontal and enamel outcomes without significantly affecting tooth movement. Most evidence derived from preclinical models showed mechanistic consistency but limited clinical applicability. Overall certainty of evidence ranged from low to very low. Conclusions: Pharmacological agents can influence orthodontic outcomes, particularly pain perception and tooth movement rate. A thorough medication history is essential during orthodontic treatment planning. Current evidence remains limited, highlighting the need for well-designed clinical trials to support personalized orthodontic care.

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}
- **Diseases:** impaired bone metabolism (MESH:D001851), root resorption (MESH:D012391), bone resorption (MESH:D001862), injury to (MESH:D014947), inflammation (MESH:D007249), anchorage loss (MESH:D016388), taste alteration (MESH:D004408), Pain (MESH:D010146), OTM (MESH:D014076), periodontal complications (MESH:D010510), movement (MESH:D009069), gingival overgrowth (MESH:D019214), craniofacial anomalies (MESH:D019465), caries (MESH:D003731), tooth staining (MESH:D019339), tooth displacement (MESH:D006617)
- **Chemicals:** Chlorhexidine (MESH:D002710), metformin (MESH:D008687), testosterone (MESH:D013739), fluoride (MESH:D005459), prostaglandin (MESH:D011453), vitamin E (MESH:D014810), Ibuprofen (MESH:D007052), Vitamin D (MESH:D014807), Acetaminophen (MESH:D000082), simvastatin (MESH:D019821), bisphosphonate (MESH:D004164), meloxicam (MESH:D000077239), methylphenidate (MESH:D008774), PGE1 (MESH:D000527), nicotine (MESH:D009538), anti- (-), cyclosporine (MESH:D016572)
- **Species:** Streptococcus mutans (species) [taxon 1309], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938123/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938123/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938123/full.md

---
Source: https://tomesphere.com/paper/PMC12938123